ArchiMed-backed NAMSA buys Clinlogix

NAMSA, which is backed by ArchiMed, has acquired Clinlogix, a provider of outsourced services for healthcare testing and clinical trials.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this